PedAM
Pediatric Disease Annotations & Medicines
| Disease | hypoglycemia |
| Phenotype | C0011860|type 2 diabetes mellitus |
| Sentences | 25 |
| PubMedID- 24030920 | The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis. |
| PubMedID- 26254702 | The primary objective of this 9-week study was to determine the frequency of hypoglycemia in patients with stable insulin-treated type 2 diabetes mellitus by comparing self-monitored blood glucose (smbg) measurement with continuous glucose monitoring (cgm). |
| PubMedID- 25325279 | Optimal candidates for the switch from glimepiride to sitagliptin to reduce hypoglycemia in patients with type 2 diabetes mellitus. |
| PubMedID- 23067027 | Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues bid in outpatient settings. |
| PubMedID- 24450135 | [case report; a case of type 2 diabetes mellitus with frequent hypoglycemia due to insulin antibodies after switching insulin product]. |
| PubMedID- 21437076 | Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus. |
| PubMedID- 24855344 | Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence. |
| PubMedID- 21199269 | Aim: the objective of this systematic review and meta-analysis was to assess the effect of pramlintide on glycemic control, weight and incidence of nausea and hypoglycaemia in patients with type 2 diabetes mellitus (t2dm) and in obese patients without diabetes (obp). |
| PubMedID- 24437153 | [quality of life and problems posed by hypoglycemia in type 2 diabetes mellitus during oral hypoglycemic therapy]. |
| PubMedID- 23683002 | Aim: to compare the impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes mellitus (t2dm) treated with insulin glargine or nph insulin. |
| PubMedID- 25765720 | Objective: reported rates of hypoglycemia in patients with type 2 diabetes mellitus are lower with glimepiride as compared to glyburide. |
| PubMedID- 25263824 | Quality of life and fear for hypoglycaemia in patients with type 2 diabetes mellitus. |
| PubMedID- 24548693 | Aims: the global attitude of patients and physicians 2 (gapp2) survey sought to address gaps in understanding about real-world basal insulin-taking behaviour and self-treated hypoglycaemia in patients with type 2 diabetes mellitus. |
| PubMedID- 24185751 | Bariatric teams performing lsg for morbid obesity should heighten their sensitivity to postoperative hypoglycemia, even in patients with type 2 diabetes mellitus. |
| PubMedID- 23859434 | Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies. |
| PubMedID- 21195501 | Self-reported experience of hypoglycemia among adults with type 2 diabetes mellitus (exhype). |
| PubMedID- 23748506 | Background and aim: exenatide is a glucagon-like peptide-1 receptor agonist demonstrated to improve glycemic control with low hypoglycemia risk in patients with type 2 diabetes mellitus. |
| PubMedID- 26417415 | Thus, further studies are required regarding fear of hypoglycemia in patients with type 2 diabetes mellitus. |
| PubMedID- 25647516 | This study describes demographic characteristics, comorbidities, and hypoglycemia events in patients with type 2 diabetes mellitus (t2dm) identified using 2011 medicare 5% standard analytical files. |
| PubMedID- 23874102 | Fear and psychological discomfort were observed as important aggravating factors of hypoglycemia among patients with type 2 diabetes mellitus (table 3). |
| PubMedID- 26229480 | hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the french health insurance database. |
| PubMedID- 25937182 | Increasing trend in emergency department visits for hypoglycemia from patients with type 2 diabetes mellitus in taiwan. |
| PubMedID- 25782322 | It is concluded that evaluation of quality of life and hypoglycemia-related symptoms in patients with type 2 diabetes mellitus on basal-bolus insulin therapy allows for comprehensive estimation of the effectiveness of therapy on an individual basis. |
| PubMedID- 24147203 | Glucagon-like peptide-1 (glp-1) receptor agonists result in greater improvements in glycemic control than placebo and promote weight loss with minimal hypoglycemia in patients with type 2 diabetes mellitus. |
| PubMedID- 21231863 | The objective of this study was to compare healthcare utilization, costs, adherence, and hypoglycemia rates in patients with type 2 diabetes mellitus (t2dm) initiating rapid-acting insulin analog (raia) using prefilled pen versus vial/syringe. |
Page: 1